Clinicopathologic significance and therapeutic implication of de novo CD5+ diffuse large B-cell lymphoma.
CONCLUSION: CD5+ DLBCL patients have the distinctive clinical and biological features, they should be provided with clinic individualized treatment and important pathways with therapeutic implications should be underscored.
PMID: 31072235 [PubMed - in process]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research
More News: Chemotherapy | China Health | Hematology | Lymphoma | Molecular Biology | Rituxan | Study